Timothy Sullivan, President & Chief Executive Officer
Timothy Sullivan is Co-Founder, President & CEO of Mystic Pharmaceuticals. Over the past 37 years he has created novel technologies, products, and services and grown seven companies, three of which were acquired by major corporations. Mr. Sullivan is co-inventor of Mystic’s novel drug delivery technology platforms and responsible for defining both the technological and strategic direction of Mystic. He has recruited and led a highly accomplished team of scientists, engineers and business professionals through early stage R&D programs, clinical trials and the deployment of a cGMP production facility for Mystic’s innovative delivery technologies. He holds ten issued/pending patents in the field of drug/biologic packaging and delivery.
Previously, Mr. Sullivan was co-founder of INFUSE Corporation, a strategy-consulting firm where he served as a Principal Consultant for organizations ranging from Fortune 500 companies to emerging companies spanning telecommunications, energy, life sciences, high technology and education. Mr. Sullivan served as a planning and technology commercialization consultant to NASA at the Johnson Space Center and was a Co-founder of the Space Business Research Institute. He was selected as one of the top 100 notable people in the medical device industry in 2008 by MD&DI and served as the 2010 Chairman of BioAustin. Mr. Sullivan serves on the Life Science Advisory Board for the Austin Technology Incubator at the University of Texas at Austin. Mr. Sullivan holds undergraduate and graduate degrees in Business, Physics, and Strategic Foresight from the University of Wisconsin-Oshkosh and the University of Houston.
Michael Shaw, Vice President – Operations
Michael Shaw is an accomplished multi-disciplinary executive with over 20 years of professional experience, Mr. Shaw joined Mystic Pharmaceuticals in 2006. At Mystic’s headquarters, Michael is responsible for the company’s technical operations, including corporate Quality Assurance, drug and device process development and manufacturing operations, analytical chemistry, microbiology and formulation R&D. Additionally, he is responsible for deploying Mystic’s commercial expansion program. Prior to joining Mystic, Michael successfully held numerous technical, leadership and consulting roles in Pharmaceutical and Medical Device industries, including SmithKline Beecham, Barr Labs, Schein Pharmaceuticals and Matrixx Initiatives.
Michael holds multiple engineering degrees from Drexel University, and a Masters of Business Administration from Arizona State University. Additionally, he is a certified Project Managemment Professional and Six Sigma Blackbelt.